| |
| |
|
| Insider
Information: |
Ahrens Brenton Karl |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
410 |
|
|
Indirect Shares
|
280,619 |
|
|
| Direct
Value |
$636 |
|
|
|
Indirect Value
|
$36,508,532 |
|
|
| Total
Shares |
281,029 |
|
|
| Total
Value |
$36,509,167 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-9.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -398.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
Director, 10% Owner |
2005-04-19 |
0 |
2005-04-19 |
280,619 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
2014-11-17 |
0 |
2014-11-17 |
0 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Director |
2022-09-20 |
410 |
2022-09-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-20 |
4 |
S |
$1.78 |
$12,910 |
I/I |
(7,246) |
0 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-19 |
4 |
S |
$1.77 |
$26,478 |
I/I |
(15,000) |
7,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-16 |
4 |
S |
$1.90 |
$28,542 |
I/I |
(15,000) |
22,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-15 |
4 |
S |
$2.02 |
$30,272 |
I/I |
(15,000) |
37,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-14 |
4 |
S |
$2.10 |
$31,457 |
I/I |
(15,000) |
52,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-13 |
4 |
S |
$2.14 |
$32,118 |
I/I |
(15,000) |
67,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-12 |
4 |
S |
$2.31 |
$34,608 |
I/I |
(15,000) |
82,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-09 |
4 |
S |
$2.32 |
$34,730 |
I/I |
(15,000) |
97,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-08 |
4 |
S |
$2.26 |
$7,465 |
I/I |
(3,298) |
112,246 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2019-05-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,154 |
6,154 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2018-05-30 |
4 |
B |
$13.00 |
$6,586,528 |
I/I |
506,656 |
1,733,170 |
2.1 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,226,514 |
1,226,514 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • • |
2014-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,034) |
0 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • • |
2014-11-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,902,030) |
0 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • • |
2014-08-26 |
4 |
OE |
$2.08 |
$10,471 |
D/D |
5,034 |
5,034 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • • |
2012-07-24 |
4 |
B |
$9.00 |
$4,999,995 |
I/I |
555,555 |
1,902,030 |
2.25 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • • |
2012-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,346,475 |
1,346,475 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • • |
2005-04-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,093,635 |
280,619 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
